
Brii Biosciences develops therapies for infectious and central nervous system diseases with patient-centric approach.
The Scientist will conduct analytical method development and testing for oligonucleotide pipeline drugs in Brii's Shanghai laboratory.
Brii Biosciences develops therapies for infectious and central nervous system diseases with patient-centric approach.